| Size & multiples | |||
| Market Cap | $990.3M | Enterprise Value | $1.07B |
| P/E (TTM) | — | PEG (trailing) | — |
| P/S | 4.84× | P/FCF | — |
| EV/EBITDA | — | EV/EBIT | — |
| EV/Sales | 5.20× | EV/FCF | — |
| FCF Yield | −5.31% | Buyback Yield | — |
| Owner Earnings (TTM) | -$67.5M | Owner Earnings Yield | −6.81% |
| Shareholder Yield | — | ||
| Cost of capital & EVAmethodology → | |||
| Beta (5y monthly) | 0.60 | Risk-free (assumed) | 4.00% |
| Equity risk premium (assumed) | 5.00% | Cost of Equity | 7.02% |
| After-tax Cost of Debt | — | WACC | — |
| ROIC | −34.07% | EVA Spread (ROIC−WACC) | — |
| EVA | — | ||
Flows TTM (last 4 quarters); latest annual for: EPS (Diluted), Gross Profit · EPS TTM -$0.90 · revenue TTM $204.7M · FCF TTM -$52.6M
Output of a disclosed model whose assumptions may be wrong — research information, not investment advice. See the Disclaimer.
Compared against all 1054 Health Care names we cover — one sector-wide pool, so the median skews toward smaller (often unprofitable) companies. Try the Size band for a cap-matched read.
| Metric | This (FY) | Peer median | IQR (25–75) | %ile |
|---|---|---|---|---|
| FCF Yield | -7.1% | -7.8% | -34.7%–1.4% | 52 ↑strong |
| Net Margin | -70.4% | -21.2% | -325.3%–7.2% | 39 ↓weak |
| Operating Margin | -115.9% | -34.5% | -552.0%–8.0% | 39 ↓weak |
| ROE | -48.6% | -36.8% | -92.5%–4.5% | 44 ↓weak |
